| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |